Mice Model Market By Type (Inbred Mice, Genetically Engineered Mice, Conditioned/Surgically Modified Mice, Hybrid/Congenic Mice, Outbred Mice and Spontaneous Mutant Mice), By Technology (CRISPR, Microinjection, Embryonic Stem Cell Injection, Nuclear Transfer and Other Technologies), By Application (Oncology Studies, Immunology and Inflammation Studies, Diabetes Studies, Cardiovascular Studies, Central Nervous System Studies and Other Diseases), By Service (Breeding Services, Cryopreservation, Quarantine, Rederivation, Genetic Testing, Model in licensing and Other Services) and Geography

 

Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Mice Model Market size was valued at USD 2.5 billion in 2021, growing at a CAGR of 6.6% from 2022-28. Global Mice Model Market report gives a comprehensive outlook on mice models across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report gives historical, current, and future market sizes (US$ Bn) on the basis of type, technology, application, service, and region. This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities, and possible challenges to the key stakeholders operating in the market. In addition, the report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the global mice model market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the report include suppliers, manufacturers, marketers, policymakers, and service providers engaged in global mice model products. Inbred Mice accounted for a larger revenue share in the market with a CAGR of XX% and is expected to grow over the forecast years. Inbred mice were necessary animal models for logical research during the twentieth century and will give crucial results in the current and subsequent centuries. They offer very functional animal models with obvious advantages when compared with outbred, that is, highly variable, populations.

Global Mice Model Market Summary

Study Period

2023-29

Base Year

2022

CAGR

6.6%

Largest Market

North America

Fastest Growing Market

Asia Pacific
Drivers And Restraints

Some of the key factors fueling the market growth include growing consumption of personalized medicine, rising number of pharmaceutical R&D activities, increasing innovation in mice models, continuous support in the form of grants and investments, rising demand for humanized mice models, physiological similarities between human and mice and rising prevalence of cancer. However, growing use of rat models, alternatives to animal testing and increased benefits from cryopreservation are factors restricting the market growth.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market and forecast (2021-2027)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Global Mice Model Market Segmentation

By Type
  • Inbred Mice
  • Genetically Engineered Mice
  • Conditioned/Surgically Modified Mice
  • Hybrid/Congenic Mice
  • Outbred Mice
  • Spontaneous Mutant Mice
By Technology
  • CRISPR
  • Microinjection
  • Embryonic Stem Cell Injection
  • Nuclear Transfer
  • Other Technologies
By Application
  • Oncology Studies
  • Immunology and Inflammation Studies
  • Diabetes Studies
  • Cardiovascular Studies
  • Central Nervous System Studies
  • Other Diseases
By Service
  • Breeding Services
  • Cryopreservation
  • Quarantine
  • Rederivation
  • Genetic Testing
  • Model in licensing
  • Other Services

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

  • Charles River Laboratories International Inc.
  • ENVIGO
  • Genoway
  • Horizon Discovery Group PLC (Sage Labs Inc.)
  • Ingenious Targeting Laboratory
  • Janvier Labs
  • Taconic Biosciences Inc.
  • The Jackson Laboratory
  • Trans Genic Inc.